Evidence map›Paper›PMID 41079964›Full record

ArticleAntimicrobial stewardship & healthcare epidemiology : ASHE2025

Decolonization of methicillin-resistant

Tiina Haapia, Jaana Vuopio, Harri Marttila, Jaakko Silvola, Tero Vahlberg, Mari Kanerva, MRSA Study Group

Erratum issuedAbstract read
In one paragraph

Article in Antimicrobial stewardship & healthcare epidemiology : ASHE, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Decolonization of methicillin-resistantAntimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Tiina HaapiaInfection Control Unit, Turku University Hospital, The Wellbeing Services County of Southwest Finland, Turku, Finland.ORCID https://orcid.org/0000-0002-0717-4578
Jaana VuopioInstitute of Biomedicine, University of Turku, Turku, Finland.ORCID https://orcid.org/0000-0002-0795-4822
Harri MarttilaInfection Control Unit, Turku University Hospital, The Wellbeing Services County of Southwest Finland, Turku, Finland.
Jaakko SilvolaInstitute of Biomedicine, University of Turku, Turku, Finland.ORCID https://orcid.org/0000-0002-0814-651X
Tero VahlbergDepartment of Biostatistics, University of Turku and Turku University Hospital, Turku, Finland.ORCID https://orcid.org/0000-0002-4935-3056
Mari KanervaInfection Control Unit, Turku University Hospital, The Wellbeing Services County of Southwest Finland, Turku, Finland.ORCID https://orcid.org/0000-0002-1993-2532
MRSA Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The aim of this study was to describe the efficacy of decolonization treatments given in Hospital District of Southwest Finland (HDSWF) in 2007-2016 and to analyze the key elements for successful decolonization treatment. Duration of follow-up varied from 12 to 15 months. Methods: All new MRSA cases detected between 2007 and 2016 in HDSWF (population 475,000) and their MRSA follow-up screening results within 12-15 months were retrospectively analyzed. This study focused on the outpatient carriers having received decolonization treatment during the study period. Results: Of the 983 MRSA cases detected during 2007-2016, 117 carriers went through decolonization treatment. Of those successfully followed up, 72/92 (78.3%) were successfully decolonized. Multisite carriage was a risk factor for unsuccessful decolonization. Conclusion: Decolonization treatment, including nasal mupirocin, chlorhexidine containing skin washes and in selected cases, also systemic antibiotics, was effective in outpatient settings, resulting in long-term clearance of the MRSA carriage.

Identifiers

PMID41079964
PMCPMC12509158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.